SEC Form 4 · accession 0001104659-18-022141
NOVELION THERAPEUTICS INC. · NVLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benjamin Harshbarger
Officer — General Counsel
Period of report
Apr 1, 2018
Accepted (ET)
Apr 3, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827809
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 1, 2018 | F | 52 | $3.50 | D | 4,465 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to the vesting of 177 restricted stock units on April 1, 2018.
- F2This total includes 2,667 unvested restricted stock units which were reported in Table II at the time the restricted stock unit awards were granted, as well as the shares settled after the tax withholding and vesting event described in footnote number 1. Each restricted stock unit represents a contingent right to receive one common share.